About us   Contacts   Links   Information in Russian 
Research programms
Publications

Abstracts 2014


1. Nikitina T.P. The effectiveness of Elima gel film in comparison with standard treatment with Vitamin F99 cream in patients with palmar-plantar syndrome developed against the background of antitumor therapy: the results of a pilot multicentre study / T.P. Nikitina, I.S. Bazin, G.P. Kolesnikov, M.V. Panina, P.S., K.A. Borisov, T.I. Ionova, K.A. Kurbatova // Malignant tumours. – 2014. – Vol. 3: 196-197. (In Russian)

2. Ionova T.I. Questionnaire for a full-scale evaluation of symptoms in patients with chronic myelogenous leukemia - Csp Leuk-CML: results of a validation study / T.I. Ionova, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova // XI International Symposium "Hematopoietic Stem Cell Transplantation. Gene and Cellular Therapy", in memory of Raisa Gorbachev. (In Russian)

3. Ionova T.I. Base-line Quality of Life Impairment and Its Potential Prognostic Value in Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (AHSCT) / T.I. Ionova, V.Y. Melnichenko, D.A. Fedorenko, T.P. Nikita, E. Mochkin, K.A.Kurbatova, G. Gorodokin, A.A. Novik.// Bone Marrow Transplantation. 2014. Vol. 49 (Suppl. 1, March): 170.

4. Nikitina T.P. Comprehensive symptom profile in patients with chronic myeloid leukemia: practicability and sensitivity of the new symptom assessment tool CSP Leuk-CML / T.P. Nikitina, D.A. Fedorenko, K.A. Kurbatova, E.I. Usacheva, T.I. Ionova, G.I. Gorodokin, A.A. Novik // Haematologica. 2014 (Suppl.): B1674.

5. Ionova T.I. The value of dasatinib therapy in patients with imatinib-resistant or -intolerant chronic myeloid leukemia from physician's and patient's perspective: "real world" outcomes / T.I. Ionova, T.P. Nikitina, T.A. Gritsenko, V.L. Ivanova, G.B. Kuchma, T.V. Shnaider, I.V. Sannikova, E.I. Usacheva, D.A. Fedorenko, K.A. Kurbatova // Haematologica. 2014 (Suppl.): B1675.

6. Ionova T. The usefulness of patient treatment satisfaction questionnaire (PTSQ) in diabetes mellitus (DM) patients / T. Ionova, T. Nikitina, K. Kurbatova // Value in Health. 2014. Vol. 17 (3): A256.

7. Ionova T. Applicability of the new instrument for assessment of hypoglycemia symptoms in diabetes mellitus patients / T. Ionova, T. Nikitina, K. Kurbatova // Value in Health. 2014. Vol. 17 (3): A256.

8. Nikitina T. New antioxidant-containing topical formulation for treatment of Hand-Foot Syndrome in cancer patients: physician's and patient's perspective / T. Nikitina, T. Ionova, K. Kurbatova, I. Bazin, A. Belonogov, G. Kolesnikov, M. Panina, P. Borisov // Annals of Oncology. 2014. Vol. 25 (Suppl. 4): 517–541. doi:10.1093/annonc/mdu356.35.

9. Ionova T. Self-reporting Hand-Foot Syndrome (HFS) is practical in cancer patients with chemotherapy-induced dermatological toxicity / T. Ionova, T. Nikitina, K. Kurbatova // Quality of Life Research. 2014; 23 (Suppl. 1): 111.

10. Ionova T. Patient-centered evaluation of treatment outcomes in CML patients after 12 months of second-line treatment: quality of life and symptom burden / T. Ionova, D. Fedorenko, T. Nikitina, K. Kurbatova // Quality of Life Research. 2014; 23(Suppl. 1): 67.

11. Ionova T. I. Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia from Physician's and Patient's Perspective / T.I Ionova, T.P Nikitina, D.A Fedorenko, T.A Gritsenko, V.L Ivanova, G.B Kuchma, T.V Shnaider, I.V Sannikova, E.I. Usacheva, K.A. Kurbatova // Blood. 2014; 124 (21): А2644.

12. Nikitina T.P. Baseline Quality of Life in Chronic Phase Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Imatinib and its Potential Prognostic Value / T.P. Nikitina, D.A. Fedorenko, K.A. Kurbatova, T.A. Gritsenko, V.L. Ivanova, G.B. Kuchma, T.V. Shnaider, I.V. Sannikova, E.I. Usacheva, T.I. Ionova.// ELN Frontiers meeting. Abstracts. 2014: 21.









© Создание сайтов

Последнее обновление (last update): 28-09-2020









Яндекс цитирования